{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:23:10Z","timestamp":1775575390536,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Migraine is a prevalent and disabling headache disorder that affects more than 1.04 billion individuals world-wide. It can result in reduction in quality of life, increased disability, and high socio-economic burden. Nevertheless, and despite the availability of evidence-based national and international guidelines, the management of migraine patients often remains suboptimal, especially for chronic migraine (CM) patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>My-LIFE anamnesis project surveyed 201 General practitioners (GPs) from 5 European countries (France, Germany, Italy, Spain, and the UK) with the aim of understanding chronic migraine (CM) patients\u2019 management in the primary care setting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In our survey, GPs diagnosed episodic migraine (EM) more often than CM (87% vs 61%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). We found that many CM patients were not properly managed or referred to specialists, in contrast to guidelines recommendations. The main tools used by primary-care physicians included clinical interview, anamnesis guide, and patient diary. Tools used at the first visit differed from those used at follow-up visits. Up to 82% of GPs reported being responsible for management of patients diagnosed with disabling or CM and did not refer them to a specialist. Even when the GP had reported referring CM patients to a specialist, 97% of them were responsible for their follow-up. Moreover, the treatment prescribed, both acute and preventive, was not in accordance with local and international recommendations. GPs reported that they evaluated the efficacy of the treatment prescribed mainly through patient perception, and the frequency of follow-up visits was not clearly established in the primary care setting. These results suggest that CM is underdiagnosed and undertreated; thereby its management is suboptimal in the primary care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>There is a need of guidance in the primary care setting to both leverage the management of CM patients and earlier referral to specialists, when appropriate.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-020-02014-6","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T04:15:59Z","timestamp":1609733759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Current clinical practice in disabling and chronic migraine in the primary care setting: results from the European My-LIFE anamnesis survey"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7775-6576","authenticated-orcid":false,"given":"Philippe","family":"Ryvlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirill","family":"Skorobogatykh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Negro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainel","family":"Sanchez-De La Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Israel-Willner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Sundal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Anne","family":"MacGregor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel L.","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"2014_CR1","doi-asserted-by":"publisher","first-page":"ITC49","DOI":"10.7326\/AITC201704040","volume":"166","author":"A MacGregor","year":"2017","unstructured":"MacGregor A. Migraine Ann Intern Med. 2017;166:ITC49\u201364.","journal-title":"Migraine Ann Intern Med"},{"key":"2014_CR2","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"LJ Stovner","year":"2018","unstructured":"Stovner LJ, Nichols E, Steiner TJ, Abd-Allah F, Abdelalim A, Al-Raddadi RM, et al. Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018;17:954\u201376.","journal-title":"Lancet Neurol"},{"key":"2014_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1129-2377-15-1","volume":"15","author":"TJ Steiner","year":"2014","unstructured":"Steiner TJ, Stovner LJ, Katsarava Z, Lainez JM, Lampl C, Lant\u00e9ri-Minet M, et al. The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain. 2014;15:1\u201311.","journal-title":"J Headache Pain."},{"key":"2014_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s10194-018-0846-2","volume":"19","author":"TJ Steiner","year":"2018","unstructured":"Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z. Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain. 2018;19:17.","journal-title":"J Headache Pain."},{"key":"2014_CR5","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"T Vos","year":"2017","unstructured":"Vos T, Abajobir AA, Abbafati C, Abbas KM, Abate KHA-AF, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211\u201359.","journal-title":"Lancet"},{"key":"2014_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/0333102419883355","volume":"40","author":"J Xu","year":"2020","unstructured":"Xu J, Kong F, Buse DC. Predictors of episodic migraine transformation to chronic migraine: a systematic review and meta-analysis of observational cohort studies. Cephalalgia. 2020;40:503\u201316.","journal-title":"Cephalalgia."},{"key":"2014_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11916-010-0157-z","volume":"15","author":"AN Manack","year":"2011","unstructured":"Manack AN, Buse DC, Lipton RB. Chronic migraine: epidemiology and disease burden. Curr Pain Headache Rep. 2011;15:70\u20138.","journal-title":"Curr Pain Headache Rep"},{"key":"2014_CR8","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/j.1526-4610.2008.01217.x","volume":"48","author":"ME Bigal","year":"2008","unstructured":"Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48:1157\u201368.","journal-title":"Headache."},{"key":"2014_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s10194-018-0899-2","volume":"20","author":"TJ Steiner","year":"2019","unstructured":"Steiner TJ, Jensen R, Katsarava Z, Linde M, MacGregor EA, Osipova V, et al. Aids to management of headache disorders in primary care (2nd edition): on behalf of the European headache federation and lifting the burden: the global campaign against headache. J Headache Pain. 2019;20:57.","journal-title":"J Headache Pain."},{"key":"2014_CR10","first-page":"1","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1\u2013211.","journal-title":"Cephalalgia"},{"key":"2014_CR11","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/head.12878","volume":"56","author":"RB Lipton","year":"2016","unstructured":"Lipton RB, Manack Adams A, Buse DC, Fanning KM, Reed ML. A comparison of the chronic migraine epidemiology and outcomes (CaMEO) study and American Migraine Prevalence and Prevention (AMPP) study: demographics and headache-related disability. Headache. 2016;56:1280\u20139.","journal-title":"Headache."},{"key":"2014_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1177\/0333102414552532","volume":"35","author":"AM Adams","year":"2015","unstructured":"Adams AM, Serrano D, Buse DC, Reed ML, Marske V, Fanning KM, et al. The impact of chronic migraine: the chronic migraine epidemiology and outcomes (CaMEO) study methods and baseline results. Cephalalgia. 2015;35:563\u201378.","journal-title":"Cephalalgia."},{"key":"2014_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1212\/01.wnl.0000323925.29520.e7","volume":"71","author":"ME Bigal","year":"2008","unstructured":"Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology. 2008;71:559\u201366.","journal-title":"Neurology."},{"key":"2014_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/0333102415583982","volume":"36","author":"RB Lipton","year":"2016","unstructured":"Lipton RB, Serrano D, Buse DC, Pavlovic JM, Blumenfeld AM, Dodick DW, et al. Improving the detection of chronic migraine: development and validation of identify chronic migraine (ID-CM). Cephalalgia. 2016;36:203\u201315.","journal-title":"Cephalalgia."},{"key":"2014_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-018-0839-1","volume":"19","author":"Z Katsarava","year":"2018","unstructured":"Katsarava Z, Mania M, Lampl C, Herberhold J, Steiner TJ. Poor medical care for people with migraine in Europe \u2013 evidence from the Eurolight study. J Headache Pain. 2018;19:1\u20139.","journal-title":"J Headache Pain."},{"key":"2014_CR16","unstructured":"British Association for the study of headache (BASH). Guidelines for All Healthcare Professionals in the Diagnosis and Management od Migraine, Tension-Type, Cluster and Medication-Overuse Headache. 2010. http:\/\/www.bash.org.uk\/wp-content\/uploads\/2012\/07\/10102-BASH-Guidelines-update-2_v5-1-indd.pdf."},{"key":"2014_CR17","volume-title":"National Headache Managment system for adults","author":"British Association for the study of headache (BASH)","year":"2019","unstructured":"British Association for the study of headache (BASH). National Headache Managment system for adults. 2019."},{"key":"2014_CR18","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1526-4610.2011.01939.x","volume":"51","author":"A Ducros","year":"2011","unstructured":"Ducros A, Romatet S, Saint Marc T, Allaf B. Use of antimigraine treatments by general practitioners. Headache. 2011;51:1122\u201331.","journal-title":"Headache."},{"key":"2014_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1468-2982.2009.01941.x","volume":"30","author":"JL Natoli","year":"2010","unstructured":"Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010;30:599\u2013609.","journal-title":"Cephalalgia."},{"key":"2014_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10194-010-0217-0","volume":"11","author":"LJ Stovner","year":"2010","unstructured":"Stovner LJ, Andree C. Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain. 2010;11:289\u201399.","journal-title":"J Headache Pain."},{"key":"2014_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1474-4422(04)00824-5","volume":"3","author":"H-C Diener","year":"2004","unstructured":"Diener H-C, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol. 2004;3:475\u201383.","journal-title":"Lancet Neurol"},{"key":"2014_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/s10194-015-0501-0","volume":"16","author":"T Kurth","year":"2015","unstructured":"Kurth T, Buring JE, Rist PM. Headache, migraine and risk of brain tumors in women: prospective cohort study. J Headache Pain. 2015;16:501.","journal-title":"J Headache Pain."},{"key":"2014_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1468-2982.2004.00798.x","volume":"25","author":"AP Sempere","year":"2005","unstructured":"Sempere AP, Porta-Etessam J, Medrano V, Garcia-Morales I, Concepci\u00f3n L, Ramos A, et al. Neuroimaging in the evaluation of patients with non-acute headache. Cephalalgia. 2005;25:30\u20135.","journal-title":"Cephalalgia."},{"key":"2014_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1212\/WNL.0000000000006697","volume":"92","author":"TP Do","year":"2019","unstructured":"Do TP, Remmers A, Schytz HW, Schankin C, Nelson SE, Obermann M, et al. Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Neurology. 2019;92:134\u201344.","journal-title":"Neurology."},{"key":"2014_CR25","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/0333102418806864","volume":"39","author":"R Potter","year":"2019","unstructured":"Potter R, Probyn K, Bernstein C, Pincus T, Underwood M, Matharu M. Diagnostic and classification tools for chronic headache disorders: a systematic review. Cephalalgia. 2019;39:761\u201384.","journal-title":"Cephalalgia."},{"key":"2014_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1212\/01.WNL.0000078940.53438.83","volume":"61","author":"RB Lipton","year":"2003","unstructured":"Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, et al. A self-administered screener for migraine in primary care: the ID migraine validation study. Neurology. 2003;61:375\u201382.","journal-title":"Neurology."},{"key":"2014_CR27","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1526-4610.2006.00628.x","volume":"47","author":"F Brighina","year":"2007","unstructured":"Brighina F, Salemi G, Fierro B, Gasparro A, Balletta A, Aloisio A, et al. A validation study of an Italian version of the \u201cID Migraine\u201d. Headache. 2007;47:905\u20138.","journal-title":"Headache."},{"key":"2014_CR28","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.neurol.2015.04.009","volume":"171","author":"S Streel","year":"2015","unstructured":"Streel S, Donneau A-F, Hoge A, Albert A, Schoenen J, Guillaume M. One-year prevalence of migraine using a validated extended French version of the ID Migraine\u2122: A Belgian population-based study. Rev Neurol (Paris). 2015;171:707\u201314.","journal-title":"Rev Neurol (Paris)"},{"key":"2014_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s10194-019-0966-3","volume":"20","author":"S Sacco","year":"2019","unstructured":"Sacco S, Benemei S, Cevoli S, Coppola G, Cortelli P, De Cesaris F, et al. Development and validation of the ID-EC - the ITALIAN version of the identify chronic migraine. J Headache Pain. 2019;20:15.","journal-title":"J Headache Pain."},{"key":"2014_CR30","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1177\/0333102417731348","volume":"38","author":"KL Haywood","year":"2018","unstructured":"Haywood KL, Mars TS, Potter R, Patel S, Matharu M, Underwood M. Assessing the impact of headaches and the outcomes of treatment: a systematic review of patient-reported outcome measures (PROMs). Cephalalgia. 2018;38:1374\u201386.","journal-title":"Cephalalgia."},{"key":"2014_CR31","doi-asserted-by":"publisher","first-page":"e2250","DOI":"10.1212\/WNL.0000000000007452","volume":"92","author":"RB Lipton","year":"2019","unstructured":"Lipton RB, Tepper SJ, Reuter U, Silberstein S, Stewart WF, Nilsen J, et al. Erenumab in chronic migraine: patient-reported outcomes in a randomized double-blind study. Neurology. 2019;92:e2250\u201360.","journal-title":"Neurology."},{"key":"2014_CR32","doi-asserted-by":"publisher","first-page":"2514183X1882337","DOI":"10.1177\/2514183X18823377","volume":"3","author":"H-C Diener","year":"2019","unstructured":"Diener H-C, Holle-Lee D, N\u00e4gel S, Dresler T, Gaul C, G\u00f6bel H, et al. Treatment of migraine attacks and prevention of migraine: Guidelines by the German Migraine and Headache Society and the German Society of Neurology. Clin Transl Neurosci. 2019;3:2514183X18823377.","journal-title":"Clin Transl Neurosci"},{"key":"2014_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-019-1071-3","volume":"21","author":"A Negro","year":"2020","unstructured":"Negro A, Spuntarelli V, Sciattella P, Martelletti P. Rapid referral for headache management from emergency department to headache Centre: four years data. J Headache Pain. 2020;21:1\u201311.","journal-title":"J Headache Pain"},{"key":"2014_CR34","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.nrl.2017.08.002","volume":"35","author":"AB Gago-Veiga","year":"2020","unstructured":"Gago-Veiga AB, D\u00edaz de Ter\u00e1n J, Gonz\u00e1lez-Garc\u00eda N, Gonz\u00e1lez-Oria C, Gonz\u00e1lez-Quintanilla V, Minguez-Olaondo A, et al. How and when to refer patients diagnosed with secondary headache and other craniofacial pain in the Emergency Department and Primary Care: Recommendations of the Spanish Society of Neurology\u2019s Headache Study Group. Neurologia. 2020;35:323\u201331.","journal-title":"Neurologia"},{"key":"2014_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.nrl.2017.08.001","volume":"35","author":"AB Gago-Veiga","year":"2020","unstructured":"Gago-Veiga AB, Garc\u00eda-Azor\u00edn D, Mas-Sala N, Ord\u00e1s CM, Ruiz-Pi\u00f1ero M, Torres-Ferr\u00fas M, et al. How and when to refer patients diagnosed with primary headache and craniofacial neuralgia in the emergency department or primary care: recommendations of the Spanish Society of Neurology\u2019s headache study group. Neurologia. 2020;35:176\u201384.","journal-title":"Neurologia."},{"key":"2014_CR36","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1177\/0333102418781644","volume":"38","author":"D Dodick","year":"2018","unstructured":"Dodick D, Edvinsson L, Makino T, Grisold W, Sakai F, Jensen R, et al. Vancouver declaration on global headache patient advocacy 2018. Cephalalgia. 2018;38:1899\u2013909.","journal-title":"Cephalalgia."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-02014-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-020-02014-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-02014-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T06:05:57Z","timestamp":1611554757000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-02014-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2014"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-02014-6","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"9 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A space was added in the 4th author's last name in the original article. The article has been updated to rectify the error.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics Committee approval from each country of the HCP that answered the survey was deemed unnecessary according to the International Ethical Guidelines for Health-related Research Involving Humans (CIOMS, Geneva 2016), since no data from any patient was collected. Results analysed in this manuscript come from a survey among European GPs intended to gather their opinion on chronic migraine management. The survey was performed following the European General Data Protection Regulation. All survey participants gave their written consent to analyse their answers anonymously. The anonymity of the participants was secured as all answers were aggregated before their analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Ryvlin reports personal fees from Novartis, during the conduct of the study and personal fees from Eli Lilly and Novartis outside the submitted work.Dr. Skorobogatykh reports personal fees from Novartis during the conduct of the study; and personal fees from Novartis and Teva, outside the submitted work.Dr. Negro reports personal fees from Novartis during the conduct of the study, and personal fees from Allergan, Eli Lilly and Teva, outside the submitted work.Dr. Sanchez-De La Rosa reports he is an employee and stakeholder of Novartis Pharma AG.Dr. Israel-Willner has nothing to disclose.Dr. Sundal reports personal fees from Novartis, during the conduct of the study and personal fees from Allergan, outside the submitted work.Dr. MacGregor reports personal fees from Novartis, during the conduct of the study; personal fees from Eli Lilly, outside the submitted work; and Co-author of Aids to management of headache disorders in primary care (2nd edition): On behalf of the European Headache Federation and Lifting the Burden: The Global Campaign against Headache. Vol. 20, Journal of Headache and Pain. The Journal of Headache and Pain; 2019.Dr. Guerrero reports personal fees from Novartis during the conduct of the study, and personal fees from Allergan, Exeltis, Eli Lilly and Teva outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}